Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.9% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.48% |
| 5 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Santander
BSBR
$43.2B
| $30.2M | 0.02% |
2,597,994
-269,561
| -9% | -$2.89M |
|
777
Pultegroup
PHM
$24.9B
| $30.2M | 0.02% |
777,367
+236,500
| +44% | +$9.19M |
|
778
Synopsys
SNPS
$78.8B
| $30.1M | 0.02% |
215,934
-2,000
| -0.9% | -$274K |
|
|
LGTY
779
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $30M | 0.02% |
2,014,600
-41,100
| -2% | -$646K |
|
780
Ashland
ASH
$3.36B
| $30M | 0.02% |
391,575
-13,100
| -3% | -$994K |
|
781
Seaboard Corp
SEB
$4.08B
| $29.9M | 0.02% |
7,035
-36
| -0.5% | -$151K |
|
782
Safety Insurance
SAFT
$1.52B
| $29.8M | 0.02% |
322,100
-14,100
| -4% | -$1.37M |
|
783
Future Fuel
FF
$249M
| $29.8M | 0.02% |
2,402,393
+115,593
| +5% | +$1.38M |
|
784
Masco
MAS
$14.7B
| $29.8M | 0.02% |
620,200
-384,252
| -38% | -$17.5M |
|
785
Powell Industries
POWL
$7.43B
| $29.7M | 0.02% |
1,820,694
+3,192
| +0.2% | +$44.8K |
|
786
Provident Financial Services
PFS
$3.26B
| $29.7M | 0.02% |
1,205,500
-100,600
| -8% | -$2.48M |
|
787
Sterling Infrastructure
STRL
$16.9B
| $29.7M | 0.02% |
2,108,500
+69,500
| +3% | +$1.05M |
|
788
Shake Shack
SHAK
$2.98B
| $29.6M | 0.02% |
497,500
-1,233,898
| -71% | -$88.7M |
|
|
BFS
789
Saul Centers
BFS
$865M
| $29.6M | 0.02% |
561,474
+23,700
| +4% | +$1.25M |
|
790
Mativ Holdings
MATV
$667M
| $29.5M | 0.02% |
702,298
+121,935
| +21% | +$5.07M |
|
|
UCB
791
United Community Banks
UCB
$4.43B
| $29.4M | 0.02% |
952,868
-73,100
| -7% | -$2.21M |
|
792
Hasbro
HAS
$13.6B
| $29.3M | 0.02% |
+277,900
| New | +$28.9M |
|
|
CBPX
793
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
| $29.3M | 0.02% |
803,499
+606,299
| +307% | +$19.9M |
|
794
Central Garden & Pet Co Class A
CENTA
$2.41B
| $29.3M | 0.02% |
1,246,000
+89,750
| +8% | +$2.02M |
|
|
TWO
795
Two Harbors Investment
TWO
$1.26B
| $29.2M | 0.02% |
500,133
+272,643
| +120% | +$15.5M |
|
|
FBM
796
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
| $29.2M | 0.02% |
1,508,100
+415,100
| +38% | +$7.97M |
|
797
Graphic Packaging
GPK
$3.51B
| $29.1M | 0.02% |
1,748,418
+469,600
| +37% | +$7.44M |
|
798
Bio-Rad Laboratories Class A
BIO
$9.66B
| $29M | 0.02% |
78,400
+25,100
| +47% | +$8.85M |
|
799
MSC Industrial Direct
MSM
$6.77B
| $29M | 0.02% |
369,100
+213,100
| +137% | +$15.7M |
|
800
Bread Financial
BFH
$4.51B
| $28.9M | 0.02% |
+322,324
| New | +$28.5M |
|
Similar funds
Jim Simons's Q4 2019 Portfolio in Review
As of Q4 2019, Jim Simons held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Jim Simons added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Jim Simons's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Jim Simons fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Jim Simons's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Jim Simons opened 518 new positions and closed 443 in Q4 2019.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.